KRAS and pancreatic intraductal papillary-mucinous neoplasm: Mateos et al. [20] reported the presence of TP53/KRAS mutations in pancreatic juice-derived cfDNA for detecting PDAC concomitant with intraductal papillary mucinous neoplasm (IPMN)/malignant IPMN.